SOBI:STO
Swedish Orphan Biovitrum AB (publ)
428,80 SEK
arrow_upward
+0,37%(+1,60) 1D
14 tet, 1:17:44 m.d., GMT+2 · SEK
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për SOBI...
Hap
427,40 SEK
I lartë
429,40 SEK
I ulët
424,80 SEK
Kapitalizimi i tregut
153,35 mld
Vëllimi mesatar
255,84 mijë
Vëllimi
62,20 mijë
Raporti çmim/fitim
114,53
Maksimumi 52-javor
487,00 SEK
Minimumi 52-javor
293,60 SEK
Fitimet për aksion
3,74 SEK
Aksionet në qarkullim
357,64 mln
Numri i punonjësve
2 mijë
Hap
427,40 SEK
I lartë
429,40 SEK
I ulët
424,80 SEK
Kapitalizimi i tregut
153,35 mld
Vëllimi mesatar
255,84 mijë
Vëllimi
62,20 mijë
Raporti çmim/fitim
114,53
Maksimumi 52-javor
487,00 SEK
Minimumi 52-javor
293,60 SEK
Fitimet për aksion
3,74 SEK
Aksionet në qarkullim
357,64 mln
Numri i punonjësve
2 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Simply Wall Street
·
7 minuta më parë
AI Chips Today - AI Infrastructure Evolves With Strategic Partnerships And Innovations
GlobeNewswire
·
1 orë më parë
Owlting Group (NASDAQ: OWLS) and Decaf Open U.S. Dollar Accounts Beyond the United States on OwlPay Harbor
Cryptonews.net
·
2 minuta më parë
XRP-Fueled Evernorth Set for NASDAQ Bell Amid $450 Million Valuation Disconnect
24/7 Wall St.
·
19 minuta më parë
Jim Cramer Says Most of the Market Is Already in a Bear Market Despite S&P 500 Rally
Profili
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Rreth Swedish Orphan Biovitrum AB (publ)